[4-[[2-(4-chlorophenyl)-6-cyclopropylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-diazepan-1-yl]-(3-fluorophenyl)methanone;4-[[2-(2,4-dichlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine

C114H100Cl5F3N16O4 — CID 159098161

IUPAC[4-[[2-(4-chlorophenyl)-6-cyclopropylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-diazepan-1-yl]-(3-fluorophenyl)methanone;4-[[2-(2,4-dichlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine
SMILESClc1ccc(-c2nc3ccc(-c4ccccc4)cn3c2CN2CCOCC2)c(Cl)c1.O=C(c1ccc(F)cc1)N1CCN(Cc2c(-c3ccc(Cl)cc3)nc3ccc(C4CC4)cn23)CC1.O=C(c1ccc(F)cc1)N1CCN(Cc2c(-c3ccc(Cl)cc3)nc3cnc(-c4ccccc4)cn23)CC1.O=C(c1cccc(F)c1)N1CCCN(Cc2c(-c3ccc(Cl)cc3)nc3ccc(-c4ccccc4)cn23)CC1
InChIInChI=1S/C32H28ClFN4O.C30H25ClFN5O.C28H26ClFN4O.C24H21Cl2N3O/c33-27-13-10-24(11-14-27)31-29(38-21-26(12-15-30(38)35-31)23-6-2-1-3-7-23)22-36-16-5-17-37(19-18-36)32(39)25-8-4-9-28(34)20-25;31-24-10-6-22(7-11-24)29-27(37-19-26(33-18-28(37)34-29)21-4-2-1-3-5-21)20-35-14-16-36(17-15-35)30(38)23-8-12-25(32)13-9-23;29-23-8-3-20(4-9-23)27-25(34-17-22(19-1-2-19)7-12-26(34)31-27)18-32-13-15-33(16-14-32)28(35)21-5-10-24(30)11-6-21;25-19-7-8-20(21(26)14-19)24-22(16-28-10-12-30-13-11-28)29-15-18(6-9-23(29)27-24)17-4-2-1-3-5-17/h1-4,6-15,20-21H,5,16-19,22H2;1-13,18-19H,14-17,20H2;3-12,17,19H,1-2,13-16,18H2;1-9,14-15H,10-13,16H2
InChIKeyKCXYIGUHSHDNNP-UHFFFAOYSA-N
MW1992.42 g/mol
LogP24.06
Rot. Bonds19

About [4-[[2-(4-chlorophenyl)-6-cyclopropylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-diazepan-1-yl]-(3-fluorophenyl)methanone;4-[[2-(2,4-dichlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine

[4-[[2-(4-chlorophenyl)-6-cyclopropylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-diazepan-1-yl]-(3-fluorophenyl)methanone;4-[[2-(2,4-dichlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine (PubChem CID 159098161) has the molecular formula C114H100Cl5F3N16O4 and a molecular weight of 1992.42 g/mol. Its IUPAC name is [4-[[2-(4-chlorophenyl)-6-cyclopropylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-diazepan-1-yl]-(3-fluorophenyl)methanone;4-[[2-(2,4-dichlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine.

Molecular Properties

Compound Name[4-[[2-(4-chlorophenyl)-6-cyclopropylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-diazepan-1-yl]-(3-fluorophenyl)methanone;4-[[2-(2,4-dichlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine
PubChem CID159098161
Molecular FormulaC114H100Cl5F3N16O4
Molecular Weight1992.42 g/mol
Exact Mass1988.65
IUPAC Name[4-[[2-(4-chlorophenyl)-6-cyclopropylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-diazepan-1-yl]-(3-fluorophenyl)methanone;4-[[2-(2,4-dichlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine
SMILESClc1ccc(-c2nc3ccc(-c4ccccc4)cn3c2CN2CCOCC2)c(Cl)c1.O=C(c1ccc(F)cc1)N1CCN(Cc2c(-c3ccc(Cl)cc3)nc3ccc(C4CC4)cn23)CC1.O=C(c1ccc(F)cc1)N1CCN(Cc2c(-c3ccc(Cl)cc3)nc3cnc(-c4ccccc4)cn23)CC1.O=C(c1cccc(F)c1)N1CCCN(Cc2c(-c3ccc(Cl)cc3)nc3ccc(-c4ccccc4)cn23)CC1
InChIInChI=1S/C32H28ClFN4O.C30H25ClFN5O.C28H26ClFN4O.C24H21Cl2N3O/c33-27-13-10-24(11-14-27)31-29(38-21-26(12-15-30(38)35-31)23-6-2-1-3-7-23)22-36-16-5-17-37(19-18-36)32(39)25-8-4-9-28(34)20-25;31-24-10-6-22(7-11-24)29-27(37-19-26(33-18-28(37)34-29)21-4-2-1-3-5-21)20-35-14-16-36(17-15-35)30(38)23-8-12-25(32)13-9-23;29-23-8-3-20(4-9-23)27-25(34-17-22(19-1-2-19)7-12-26(34)31-27)18-32-13-15-33(16-14-32)28(35)21-5-10-24(30)11-6-21;25-19-7-8-20(21(26)14-19)24-22(16-28-10-12-30-13-11-28)29-15-18(6-9-23(29)27-24)17-4-2-1-3-5-17/h1-4,6-15,20-21H,5,16-19,22H2;1-13,18-19H,14-17,20H2;3-12,17,19H,1-2,13-16,18H2;1-9,14-15H,10-13,16H2
InChIKeyKCXYIGUHSHDNNP-UHFFFAOYSA-N
XLogP24.06
TPSA165.21 Ų
H-Bond Donors
H-Bond Acceptors17
Rotatable Bonds19
Heavy Atoms142
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001992.42
LogP ≤ 524.06
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1017

Analyze [4-[[2-(4-chlorophenyl)-6-cyclopropylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-diazepan-1-yl]-(3-fluorophenyl)methanone;4-[[2-(2,4-dichlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [4-[[2-(4-chlorophenyl)-6-cyclopropylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-diazepan-1-yl]-(3-fluorophenyl)methanone;4-[[2-(2,4-dichlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine?
The IUPAC name of [4-[[2-(4-chlorophenyl)-6-cyclopropylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-diazepan-1-yl]-(3-fluorophenyl)methanone;4-[[2-(2,4-dichlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine (CID 159098161) is [4-[[2-(4-chlorophenyl)-6-cyclopropylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-diazepan-1-yl]-(3-fluorophenyl)methanone;4-[[2-(2,4-dichlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine.
What is the SMILES notation for [4-[[2-(4-chlorophenyl)-6-cyclopropylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-diazepan-1-yl]-(3-fluorophenyl)methanone;4-[[2-(2,4-dichlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine?
The canonical SMILES for [4-[[2-(4-chlorophenyl)-6-cyclopropylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-diazepan-1-yl]-(3-fluorophenyl)methanone;4-[[2-(2,4-dichlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine is Clc1ccc(-c2nc3ccc(-c4ccccc4)cn3c2CN2CCOCC2)c(Cl)c1.O=C(c1ccc(F)cc1)N1CCN(Cc2c(-c3ccc(Cl)cc3)nc3ccc(C4CC4)cn23)CC1.O=C(c1ccc(F)cc1)N1CCN(Cc2c(-c3ccc(Cl)cc3)nc3cnc(-c4ccccc4)cn23)CC1.O=C(c1cccc(F)c1)N1CCCN(Cc2c(-c3ccc(Cl)cc3)nc3ccc(-c4ccccc4)cn23)CC1.
What is the InChIKey of [4-[[2-(4-chlorophenyl)-6-cyclopropylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-diazepan-1-yl]-(3-fluorophenyl)methanone;4-[[2-(2,4-dichlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine?
The InChIKey is KCXYIGUHSHDNNP-UHFFFAOYSA-N. The full InChI is InChI=1S/C32H28ClFN4O.C30H25ClFN5O.C28H26ClFN4O.C24H21Cl2N3O/c33-27-13-10-24(11-14-27)31-29(38-21-26(12-15-30(38)35-31)23-6-2-1-3-7-23)22-36-16-5-17-37(19-18-36)32(39)25-8-4-9-28(34)20-25;31-24-10-6-22(7-11-24)29-27(37-19-26(33-18-28(37)34-29)21-4-2-1-3-5-21)20-35-14-16-36(17-15-35)30(38)23-8-12-25(32)13-9-23;29-23-8-3-20(4-9-23)27-25(34-17-22(19-1-2-19)7-12-26(34)31-27)18-32-13-15-33(16-14-32)28(35)21-5-10-24(30)11-6-21;25-19-7-8-20(21(26)14-19)24-22(16-28-10-12-30-13-11-28)29-15-18(6-9-23(29)27-24)17-4-2-1-3-5-17/h1-4,6-15,20-21H,5,16-19,22H2;1-13,18-19H,14-17,20H2;3-12,17,19H,1-2,13-16,18H2;1-9,14-15H,10-13,16H2.
What are the key properties of [4-[[2-(4-chlorophenyl)-6-cyclopropylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-diazepan-1-yl]-(3-fluorophenyl)methanone;4-[[2-(2,4-dichlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine?
[4-[[2-(4-chlorophenyl)-6-cyclopropylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-diazepan-1-yl]-(3-fluorophenyl)methanone;4-[[2-(2,4-dichlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine has a molecular weight of 1992.42 g/mol, XLogP of 24.06, 19 rotatable bonds, 0 hydrogen bond donors, and 17 hydrogen bond acceptors.
Where does this data come from?
All data for [4-[[2-(4-chlorophenyl)-6-cyclopropylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-diazepan-1-yl]-(3-fluorophenyl)methanone;4-[[2-(2,4-dichlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine is sourced from PubChem (CID 159098161), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).